We are live on ! Find out more
CCP

Corient Capital Partners Portfolio holdings

AUM $1.34B
1-Year Est. Return 12.46%
This Fund
S&P 500
This Quarter Est. Return
+9.36%
1 Year Est. Return
-12.46%
3 Year Est. Return
+39.22%
5 Year Est. Return
+66.79%
10 Year Est. Return
AUM
$870M
AUM Growth
+$49.8M
Cap. Flow
-$14.9M
Cap. Flow %
-1.71%
Top 10 Hldgs %
28.57%
Holding
533
New
40
Increased
148
Reduced
302
Closed
25

Sector Composition

Rank Sector Weight
1 Technology 19.73%
2 Healthcare 11.6%
3 Financials 10.3%
4 Consumer Discretionary 8.88%
5 Industrials 6.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFM icon
526
Sprouts Farmers Market
SFM
$7.92B
-9,103
Closed -$233K
SPYG icon
527
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.3B
-6,635
Closed -$298K
TFX icon
528
Teleflex
TFX
$6.1B
-642
Closed -$234K
VEON icon
529
VEON
VEON
$3.76B
-1,263
Closed -$57K
XRX icon
530
Xerox
XRX
$421M
-18,674
Closed -$286K
VRN
531
DELISTED
Veren
VRN
-21,783
Closed -$36K
MXIM
532
DELISTED
Maxim Integrated Products
MXIM
-15,423
Closed -$935K
IBKC
533
DELISTED
IBERIABANK Corp
IBKC
-5,101
Closed -$232K

Similar funds

Corient Capital Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Corient Capital Partners held 533 positions worth $870M, up 6.1% from $820M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Corient Capital Partners's Q3 2020 filing shows 40 new, 148 increased, 302 reduced and 25 closed positions. Its largest new stake was Block Inc: 4,265 shares worth $693K. The largest sale was Home Depot, an estimated $2.38M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • Corient Capital Partners's largest Q3 2020 buy was Block Inc: 4,265 shares worth $693K.
  • Corient Capital Partners added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $2.22M increase.
  • Corient Capital Partners's biggest Q3 2020 reduction was Home Depot, cutting an estimated $2.38M.
  • Corient Capital Partners fully exited BioMarin Pharmaceuticals in Q3 2020, selling an estimated $1.23M.
  • Corient Capital Partners's ten largest holdings make up 29% of its $870M portfolio in Q3 2020.
  • Corient Capital Partners opened 40 new positions and closed 25 in Q3 2020.
  • Corient Capital Partners's portfolio value rose 6.1% quarter-over-quarter to $870M.

Based on Corient Capital Partners's 13F filing for Q3 2020, filed 16 Nov 2020.